GRK2 Antikörper
Kurzübersicht für GRK2 Antikörper (ABIN646088)
Target
Alle GRK2 (ADRBK1) Antikörper anzeigenReaktivität
Wirt
Konjugat
Applikation
-
-
Spezifität
- Peptide ELISA: Antibody detection limit dilution 1:16000. Western Blot: Approx 75-80kDa band observed in Human lysates of Burkitt's lymphoma cell line Daudi (calculated MW of 79.7kDa according to NP_001610.1). Recommended concentration: 0.3-1.0µg/ml.
-
Kreuzreaktivität
- Human, Maus, Ratte (Rattus), Hund
-
Produktmerkmale
- Goat Anti-BARK1 / GRK2
-
Immunogen
- Peptide with sequence C-RDAYREAQQLVQR, from the internal region of the protein sequence according to NP_001610.1.
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- GRK2 (ADRBK1) (Adrenergic, Beta, Receptor Kinase 1 (ADRBK1))
-
Andere Bezeichnung
- BARK1 / GRK2
-
Hintergrund
- Synonyms: BARK1, GRK2, ADRBK1, adrenergic, beta, receptor kinase 1, BETA-ARK1, beta adrenergic receptor kinase 1
-
NCBI Accession
- NP_001610
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signalübertragung, Regulation of G-Protein Coupled Receptor Protein Signaling, CXCR4-mediated Signaling Events, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling
Target
-